<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39526116</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2046-1402</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>F1000Research</Title><ISOAbbreviation>F1000Res</ISOAbbreviation></Journal><ArticleTitle>Clinical rationale for dietary lutein supplementation in long COVID and mRNA vaccine injury syndromes.</ArticleTitle><Pagination><StartPage>191</StartPage><MedlinePgn>191</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">191</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.12688/f1000research.143517.3</ELocationID><Abstract><AbstractText>Lutein, a plant-derived xanthophyl-carotenoid, is an exceptional antioxidant and anti-inflammatory constituent found in food. High dietary intake of lutein is beneficial against eye disease, improves cardiometabolic health, protects from neurodegenerative diseases, and is beneficial for liver, kidney, and respiratory health. Lutein protects against oxidative and nitrosative stress, both of which play a major role in long COVID and mRNA vaccination injury syndromes. Lutein is an important natural agent for therapeutic use against oxidative and nitrosative stress in chronic illnesses such as cardiovascular and neurodegenerative diseases and cancer. It can also potentially inhibit spike protein-induced inflammation. Rich dietary supplementation of lutein, naturally derived in non-biodegradable Extra Virgin Olive Oil (EVOO), can most optimally be used against oxidative and nitrosative stress during post-COVID and mRNA vaccination injury syndromes. Due to its high oleic acid (OA) content, EVOO supports optimal absorption of dietary lutein. The main molecular pathways by which the SARS-CoV-2 spike protein induces pathology, nuclear factor kappa-light-chain-enhancer activated B cells (NF-&#x3ba;B) and activated protein (AP)-1, can be suppressed by lutein. Synergy with other natural compounds for spike protein detoxification is likely.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Kyriakopoulos AM et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kyriakopoulos</LastName><ForeName>Anthony M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-0749-0060</Identifier><AffiliationInfo><Affiliation>Department of Research and Development, Nasco AD Biotechnology Laboratory, Piraeus, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nigh</LastName><ForeName>Greg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Naturopathic Oncologist, Immersion Health, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCullough</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>McCullough Foundation, Dallas, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seneff</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8191-1049</Identifier><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>F1000Res</MedlineTA><NlmUniqueID>101594320</NlmUniqueID><ISSNLinking>2046-1402</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>X72A60C9MT</RegistryNumber><NameOfSubstance UI="D014975">Lutein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000087503">mRNA Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000069463">Olive Oil</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014975" MajorTopicYN="Y">Lutein</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087503" MajorTopicYN="N">mRNA Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069463" MajorTopicYN="N">Olive Oil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lutein; chronic illnesses; post-COVID and mRNA vaccination injury syndromes; inflammatory response; reactive oxygen species; extra virgin olive oil.</Keyword></KeywordList><CoiStatement>Competing interests: Dr. McCullough receives salary support and has an equity interest in The Wellness Company which had no role in the writing of the manuscript and no stake in the outcome of the paper. Dr. McCullough is President of the McCullough Foundation which has no stake in the outcome of this paper. Anthony M. Kyriakopoulos has founded Nasco AD Biotechnology Laboratory and does not receive a salary from this firm, since from its beginning it is not profitable. Anthony M. Kyriakopoulos is the inventor of US patent: https://uspto.report/patent/grant/10,772,855 that belongs to Nasco AD Biotechnology Laboratory. The patent focuses on the use of Taurine and N-Bromotaurine solutions and emulsions against abnormal cells. Patent involves also Stable Produced Olive Oil that naturally contains lutein, as any extra virgin olive oil contains lutein due to the natural maturation of olive fruits. Nasco AD Biotechnology Laboratory does not produce special products on lutein but performs basic research on the natural conservation of lutein in olive oil. Greg Nigh is a full-time clinician and has no direct or indirect financial ties to any therapies mentioned in this article. Dr. Stephanie Seneff has nothing to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>11</Day><Hour>5</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39526116</ArticleId><ArticleId IdType="pmc">PMC11549548</ArticleId><ArticleId IdType="doi">10.12688/f1000research.143517.3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitra S, Rauf A, Tareq AM, et al. : Potential health benefits of carotenoid lutein: An updated review. Food Chem. Toxicol. 2021;154:112328. 10.1016/j.fct.2021.112328</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2021.112328</ArticleId><ArticleId IdType="pubmed">34111488</ArticleId></ArticleIdList></Reference><Reference><Citation>Leermakers ET, Darweesh SK, Baena CP, et al. : The effects of lutein on cardiometabolic health across the life course: a systematic review and meta-analysis. Am. J. Clin. Nutr. 2016;103(2):481&#x2013;494. 10.3945/ajcn.115.120931</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.115.120931</ArticleId><ArticleId IdType="pubmed">26762372</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandla K, Babu AK, Unnisa A, et al. : Carotenoids: Role in neurodegenerative diseases remediation. Brain Sci. 2023;13(3):457. 10.3390/brainsci13030457</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13030457</ArticleId><ArticleId IdType="pmc">PMC10046158</ArticleId><ArticleId IdType="pubmed">36979267</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo van Lent D, Leermakers ETM, Darweesh SKL, et al. : The effects of lutein on respiratory health across the life course: A systematic review. Clin. Nutr. ESPEN. 2016;13:e1&#x2013;e7. 10.1016/j.clnesp.2016.02.096</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2016.02.096</ArticleId><ArticleId IdType="pubmed">28531562</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahmi F, Vejux A, Ghzaiel I, et al. : Role of diet and nutrients in SARS-CoV-2 infection: Incidence on oxidative stress, Inflammatory Status and Viral Production. Nutrients. 2022 May 25;14(11):2194. 10.3390/nu14112194</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14112194</ArticleId><ArticleId IdType="pmc">PMC9182601</ArticleId><ArticleId IdType="pubmed">35683996</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil A, Tazeddinova D, Aljoumaa K, et al. : Carotenoids: Therapeutic strategy in the battle against viral emerging diseases, COVID-19: An overview. Prev. Nutr. Food Sci. 2021;26(3):241&#x2013;261. 10.3746/pnf.2021.26.3.241</Citation><ArticleIdList><ArticleId IdType="doi">10.3746/pnf.2021.26.3.241</ArticleId><ArticleId IdType="pmc">PMC8531419</ArticleId><ArticleId IdType="pubmed">34737985</ArticleId></ArticleIdList></Reference><Reference><Citation>Becerra MO, Contreras LM, Lo MH, et al. : Lutein as a functional food ingredient: Stability and bioavailability. J. Funct. Foods. 2020;66:103771. 10.1016/j.jff.2019.103771</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2019.103771</ArticleId></ArticleIdList></Reference><Reference><Citation>Korobelnik JF, Rougier MB, Delyfer MN, et al. : Effect of dietary supplementation with lutein, zeaxanthin, and &#x3c9;-3 on macular pigment: A randomized clinical trial. JAMA Ophthalmol. 2017;135(11):1259&#x2013;1266. 10.1001/jamaophthalmol.2017.3398</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaophthalmol.2017.3398</ArticleId><ArticleId IdType="pmc">PMC5710391</ArticleId><ArticleId IdType="pubmed">28973076</ArticleId></ArticleIdList></Reference><Reference><Citation>Azar G, Quaranta-El Maftouhi M, Masella JJ, et al. : Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam &#xae; 200 pigment module: Impact of age-related macular degeneration and lens status. J. Fr. Ophtalmol. 2017;40(4):303&#x2013;313. 10.1016/j.jfo.2016.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfo.2016.11.009</ArticleId><ArticleId IdType="pubmed">28336284</ArticleId></ArticleIdList></Reference><Reference><Citation>Goulinet S, Chapman MJ: Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 1997;17(4):786&#x2013;796. 10.1161/01.atv.17.4.786</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.atv.17.4.786</ArticleId><ArticleId IdType="pubmed">9108795</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Aal E-SM, Akhtar H, Zaheer K, et al. : Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health. Nutrients. 2013;5(4):1169&#x2013;1185. 10.3390/nu5041169</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu5041169</ArticleId><ArticleId IdType="pmc">PMC3705341</ArticleId><ArticleId IdType="pubmed">23571649</ArticleId></ArticleIdList></Reference><Reference><Citation>Renzi LM, Hammond BR, Jr, Dengler M, et al. : The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs. Lipids Health Dis. 2012;11:33. 10.1186/1476-511X-11-33</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-511X-11-33</ArticleId><ArticleId IdType="pmc">PMC3310786</ArticleId><ArticleId IdType="pubmed">22375926</ArticleId></ArticleIdList></Reference><Reference><Citation>Broekmans WM, Berendschot TT, Kl&#xf6;pping-Ketelaars IA, et al. : Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am. J. Clin. Nutr. 2002;76(3):595&#x2013;603. 10.1093/ajcn/76.3.595</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/76.3.595</ArticleId><ArticleId IdType="pubmed">12198005</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson EJ: Obesity, lutein metabolism, and age-related macular degeneration: a web of connections. Nutr. Rev. 2005 Jan;63(1):9&#x2013;15. 10.1111/j.1753-4887.2005.tb00105.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1753-4887.2005.tb00105.x</ArticleId><ArticleId IdType="pubmed">15730230</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen LF, Jacobs DR, Jr, Gross MD, et al. : Longitudinal associations between body mass index and serum carotenoids: the CARDIA study. Br. J. Nutr. 2006;95(2):358&#x2013;365. 10.1079/bjn20051638</Citation><ArticleIdList><ArticleId IdType="doi">10.1079/bjn20051638</ArticleId><ArticleId IdType="pubmed">16469154</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, Al-Rubaye HT, Al-Hadrawi DS, et al. : Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: A proof of concept and mechanism study. Mol. Psychiatry. 2023;28(2):564&#x2013;578. 10.1038/s41380-022-01836-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Dursun AD, Saricam E, Sariyildiz GT, et al. : The evaluation of oxidative stress in the young addults with COVID-19 mRNA vaccines induced acute pericarditis- myopericarditis. Int. J. Gen. Med. 2022;15:161&#x2013;167. 10.2147/IJGM.S347977</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S347977</ArticleId><ArticleId IdType="pmc">PMC8747758</ArticleId><ArticleId IdType="pubmed">35023954</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhou Y, Ma J, et al. : The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Sig. Transduct. Target. Ther. 2023;8:416. 10.1038/s41392-023-01640-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01640-z</ArticleId><ArticleId IdType="pmc">PMC10618229</ArticleId><ArticleId IdType="pubmed">37907497</ArticleId></ArticleIdList></Reference><Reference><Citation>Finterer J, Scorza FA: A retrospective analysis of clinically confirmed long post-COVID vaccination syndrome. J. Clin. Transl. Res. 2022;8(6):506&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9706319</ArticleId><ArticleId IdType="pubmed">36452006</ArticleId></ArticleIdList></Reference><Reference><Citation>Diexer S, Klee B, Gottschick C, et al. : Association between virus variants, vaccination, previous infections, and post-COVID-19 risk. Int. J. Infect. Dis. 2023;136:14&#x2013;21. 10.1016/j.ijid.2023.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.08.019</ArticleId><ArticleId IdType="pubmed">37634619</ArticleId></ArticleIdList></Reference><Reference><Citation>Seneff S, Nigh G, Kyriakopoulos AM, et al. : Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs. Food Chem. Toxicol. 2022;164:113008. 10.1016/j.fct.2022.113008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2022.113008</ArticleId><ArticleId IdType="pmc">PMC9012513</ArticleId><ArticleId IdType="pubmed">35436552</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E, Vanella VV, Falasca M, et al. : Circulating exosomes are strongly involved in SARS-CoV-2 infection. Front. Mol. Biosci. 2021;8: 632290. 10.3389/fmolb.2021.632290</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.632290</ArticleId><ArticleId IdType="pmc">PMC7937875</ArticleId><ArticleId IdType="pubmed">33693030</ArticleId></ArticleIdList></Reference><Reference><Citation>Almas T, Rehman S, Mansour E, et al. : Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review. Biomed. Pharmacother. 2022;149: 112843. 10.1016/j.biopha.2022.112843</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.112843</ArticleId><ArticleId IdType="pmc">PMC8934717</ArticleId><ArticleId IdType="pubmed">35325848</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JK, Park SU: Current results on the potential health benefits of lutein. EXCLI J. 2016;15:308&#x2013;314. 10.17179/excli2016-278</Citation><ArticleIdList><ArticleId IdType="doi">10.17179/excli2016-278</ArticleId><ArticleId IdType="pmc">PMC4897658</ArticleId><ArticleId IdType="pubmed">27298616</ArticleId></ArticleIdList></Reference><Reference><Citation>Algan AH, Gungor-Ak A, Karatas A: Nanoscale delivery systems of lutein: An updated review from a pharmaceutical perspective. Pharmaceutics. 2022;14(9):1852. 10.3390/pharmaceutics14091852</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics14091852</ArticleId><ArticleId IdType="pmc">PMC9501598</ArticleId><ArticleId IdType="pubmed">36145601</ArticleId></ArticleIdList></Reference><Reference><Citation>Shechter A, Yelin D, Margalit I, et al. : Assessment of adult patients with long COVID manifestations suspected as cardiovascular: A single-center experience. J. Clin. Med. 2022;11:6123. 10.3390/jcm11206123</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11206123</ArticleId><ArticleId IdType="pmc">PMC9605399</ArticleId><ArticleId IdType="pubmed">36294444</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew BP, Brown CM, Park JS, et al. : Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis. Anticancer Res. 2003;23(4):3333&#x2013;3339.</Citation><ArticleIdList><ArticleId IdType="pubmed">12926072</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong X, Smith JR, Swanson HM, et al. : Carotenoid lutein selectively inhibits breast cancer cell growth and potentiates the effect of chemotherapeutic agents through ROS-mediated mechanisms. Molecules. 2018;23(4):905. 10.3390/molecules23040905</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23040905</ArticleId><ArticleId IdType="pmc">PMC6017803</ArticleId><ArticleId IdType="pubmed">29662002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung RWS, Leanderson P, Lundberg AK, et al. : Lutein exerts anti-inflammatory effects in patients with coronary artery disease. Atherosclerosis. 2017;262:87&#x2013;93. 10.1016/j.atherosclerosis.2017.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2017.05.008</ArticleId><ArticleId IdType="pubmed">28527371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Leite JO, DeOgburn R, et al. : A lutein-enriched diet prevents cholesterol accumulation and decreases oxidized LDL and inflammatory cytokines in the aorta of guinea pigs. J. Nutr. 2011;141(8):1458&#x2013;1463. 10.3945/jn.111.141630</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/jn.111.141630</ArticleId><ArticleId IdType="pubmed">21697302</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajizadeh-Sharafabad F, Ghoreishi Z, Maleki V, et al. : Mechanistic insights into the effect of lutein on atherosclerosis, vascular dysfunction, and related risk factors: A systematic review of in vivo, ex vivo and in vitro studies. Pharmacol. Res. 2019;149:104477. 10.1016/j.phrs.2019.104477</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.104477</ArticleId><ArticleId IdType="pubmed">31605782</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu XH, Yu RB, Liu R, et al. : Association between lutein and zeaxanthin status and the risk of cataract: a meta-analysis. Nutrients. 2014;6(1):452&#x2013;465. 10.3390/nu6010452</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu6010452</ArticleId><ArticleId IdType="pmc">PMC3916871</ArticleId><ArticleId IdType="pubmed">24451312</ArticleId></ArticleIdList></Reference><Reference><Citation>Buscemi S, Corleo D, Di Pace F, et al. : The effect of lutein on eye and extra-eye health. Nutrients. 2018;10(9):1321. 10.3390/nu10091321</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10091321</ArticleId><ArticleId IdType="pmc">PMC6164534</ArticleId><ArticleId IdType="pubmed">30231532</ArticleId></ArticleIdList></Reference><Reference><Citation>Junghans A, Sies H, Stahl W: Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch. Biochem. Biophys. 2001;391(2):160&#x2013;164. 10.1006/abbi.2001.2411</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.2001.2411</ArticleId><ArticleId IdType="pubmed">11437346</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakshminarayana R, Raju M, Krishnakantha TP, et al. : Lutein and zeaxanthin in leafy greens and their bioavailability: olive oil influences the absorption of dietary lutein and its accumulation in adult rats. J. Agric. Food Chem. 2007;55(15):6395&#x2013;6400. 10.1021/jf070482z</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf070482z</ArticleId><ArticleId IdType="pubmed">17602649</ArticleId></ArticleIdList></Reference><Reference><Citation>Min JY, Min KB: Serum lycopene, lutein and zeaxanthin, and the risk of Alzheimer&#x2019;s disease mortality in older adults. Dement. Geriatr. Cogn. Disord. 2014;37(3-4):246&#x2013;256. 10.1159/000356486</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000356486</ArticleId><ArticleId IdType="pubmed">24247062</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Li Y, Wu Y, et al. : Lutein suppresses inflammatory responses through Nrf2 activation and NF-&#x3ba;B inactivation in lipopolysaccharide-stimulated BV-2 microglia. Mol. Nutr. Food Res. 2015;59(9):1663&#x2013;1673. 10.1002/mnfr.201500109</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201500109</ArticleId><ArticleId IdType="pubmed">26016441</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan D, Yu X, Chen M, et al. : Lutein protects against severe traumatic brain injury through anti-inflammation and antioxidative effects via ICAM-1/Nrf-2. Mol. Med. Rep. 2017;16(4):4235&#x2013;4240. 10.3892/mmr.2017.7040</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.7040</ArticleId><ArticleId IdType="pubmed">28731190</ArticleId></ArticleIdList></Reference><Reference><Citation>Muriach M, Bosch-Morell F, Arnal E, et al. : Lutein prevents the effect of high glucose levels on immune system cells in vivo and in vitro. J. Physiol. Biochem. 2008;64(2):149&#x2013;157. 10.1007/BF03168243</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03168243</ArticleId><ArticleId IdType="pubmed">19043985</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal SS, Eligar SM, Vallikannan B, et al. : Inhibitory efficacy of lutein on adipogenesis is associated with blockage of early phase regulators of adipocyte differentiation. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2021;1866(1):158812. 10.1016/j.bbalip.2020.158812</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2020.158812</ArticleId><ArticleId IdType="pubmed">32920140</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatani AJ, Al-Rejaie SS, Parmar MY, et al. : Lutein attenuates diabetic-induced renal damage via inhibiting oxidative and nitrosative stresses. Prog. Nutr. 2017,2017;19(1):57&#x2013;66. 10.23751/pn.v19i1.4892</Citation><ArticleIdList><ArticleId IdType="doi">10.23751/pn.v19i1.4892</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu BJ, Hu YN, Lin S, et al. : Application of lutein and zeaxanthin in nonproliferative diabetic retinopathy. Int. J. Ophthalmol. 2011;4(3):303&#x2013;306. 10.3980/j.issn.2222-3959.2011.03.19</Citation><ArticleIdList><ArticleId IdType="doi">10.3980/j.issn.2222-3959.2011.03.19</ArticleId><ArticleId IdType="pmc">PMC3340817</ArticleId><ArticleId IdType="pubmed">22553667</ArticleId></ArticleIdList></Reference><Reference><Citation>Pap R, Pandur E, J&#xe1;nosa G, et al. : Lutein exerts antioxidant and Anti-inflammatory effects and influences iron utilization of BV-2 microglia. Antioxidants (Basel). 2021;10(3):363. 10.3390/antiox10030363</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10030363</ArticleId><ArticleId IdType="pmc">PMC7997267</ArticleId><ArticleId IdType="pubmed">33673707</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao SC, Nien CW, Iacob C, et al. : Effects of lutein on hyperosmoticity-induced upregulation of IL-6 in cultured corneal epithelial cells and its relevant signal pathways. J. Ophthalmol. 2016;2016:8341439. 10.1155/2016/8341439</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/8341439</ArticleId><ArticleId IdType="pmc">PMC4800098</ArticleId><ArticleId IdType="pubmed">27047687</ArticleId></ArticleIdList></Reference><Reference><Citation>Elvira-Torales LI, Garc&#xed;a-Alonso J, Periago-Cast&#xf3;n MJ: Nutritional importance of carotenoids and their effect on liver health: A review. Antioxidants (Basel). 2019;8(7):229. 10.3390/antiox8070229</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox8070229</ArticleId><ArticleId IdType="pmc">PMC6681007</ArticleId><ArticleId IdType="pubmed">31330977</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Clark RM, Park Y, et al. : Lutein decreases oxidative stress and inflammation in liver and eyes of guinea pigs fed a hypercholesterolemic diet. Nutr. Res. Pract. 2012;6(2):113&#x2013;119. 10.4162/nrp.2012.6.2.113</Citation><ArticleIdList><ArticleId IdType="doi">10.4162/nrp.2012.6.2.113</ArticleId><ArticleId IdType="pmc">PMC3349032</ArticleId><ArticleId IdType="pubmed">22586499</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharavana G, Joseph GS, Baskaran V: Lutein attenuates oxidative stress markers and ameliorates glucose homeostasis through polyol pathway in heart and kidney of STZ-induced hyperglycemic rat model. Eur. J. Nutr. 2017;56(8):2475&#x2013;2485. 10.1007/s00394-016-1283-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-016-1283-0</ArticleId><ArticleId IdType="pubmed">27488609</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang R, Tao JY, Zhang SL, et al. : In vitro antiviral activity of lutein against hepatitis B virus. Phytother. Res. 2010;24(11):1627&#x2013;1630. 10.1002/ptr.3155</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.3155</ArticleId><ArticleId IdType="pubmed">21031619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rababi D, Nag A: Evaluation of therapeutic potentials of selected phytochemicals against Nipah virus, a multi-dimensional in silico study. 3 Biotech. 2023;13(6):174. 10.1007/s13205-023-03595-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13205-023-03595-y</ArticleId><ArticleId IdType="pmc">PMC10170460</ArticleId><ArticleId IdType="pubmed">37180429</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E-A, Kang N, Heo S-Y, et al. : Antioxidant, antiviral, and anti-inflammatory activities of lutein-enriched extract of Tetraselmis species. Mar. Drugs. 2023;21(7):369. 10.3390/md21070369</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md21070369</ArticleId><ArticleId IdType="pmc">PMC10381658</ArticleId><ArticleId IdType="pubmed">37504900</ArticleId></ArticleIdList></Reference><Reference><Citation>Behera SK, Mahapatra N, Tripathy CS, et al. : Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in-silico approach. Indian J. Med. Res. 2021;153(1 &amp; 2):132&#x2013;143. 10.4103/ijmr.IJMR_1132_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijmr.IJMR_1132_20</ArticleId><ArticleId IdType="pmc">PMC8184087</ArticleId><ArticleId IdType="pubmed">33818470</ArticleId></ArticleIdList></Reference><Reference><Citation>Kafi DK, Ayyash AN: Density functional theory and molecular docking study to lutein molecule for COVID-19 protease inhibitors. Appl. Nanosci. 2023;13:5477&#x2013;5488. 10.1007/s13204-022-02735-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13204-022-02735-9</ArticleId><ArticleId IdType="pmc">PMC9850325</ArticleId><ArticleId IdType="pubmed">36691520</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouznetsova VL, Zhang A, Miller MA, et al. : Potential SARS-CoV-2 spike protein-ACE2 interface inhibitors: Repurposing FDA-approved drugs. J. Explor. Res. Pharmacol. 2022;7(1):17&#x2013;29. 10.14218/JERP.2021.00050</Citation><ArticleIdList><ArticleId IdType="doi">10.14218/JERP.2021.00050</ArticleId></ArticleIdList></Reference><Reference><Citation>Krinsky NI, Johnson EJ: Carotenoid actions and their relation to health and disease. Mol. Asp. Med. 2005;26(6):459&#x2013;516. 10.1016/j.mam.2005.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2005.10.001</ArticleId><ArticleId IdType="pubmed">16309738</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin ZX, Zhang M, Yang R, et al. : The anti-inflammatory effect of lutein in broilers is mediated by regulating Toll-like receptor 4/myeloid-differentiation-factor 88 signaling pathway. Poult. Sci. 2023;102(6):102622. 10.1016/j.psj.2023.102622</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psj.2023.102622</ArticleId><ArticleId IdType="pmc">PMC10122034</ArticleId><ArticleId IdType="pubmed">37019074</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaure C, Liu Y: A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front. Immunol. 2014;5:316. 10.3389/fimmu.2014.00316</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00316</ArticleId><ArticleId IdType="pmc">PMC4090903</ArticleId><ArticleId IdType="pubmed">25071777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Kuang M, Li J, et al. : SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res. 2021;31(7):818&#x2013;820. 10.1038/s41422-021-00495-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00495-9</ArticleId><ArticleId IdType="pmc">PMC7975240</ArticleId><ArticleId IdType="pubmed">33742149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircheis R, Planz O: Could a Lower Toll-like receptor (TLR) and NF-&#x3ba;B activation due to a changed charge distribution in the spike protein be the reason for the lower pathogenicity of omicron? Int. J. Mol. Sci. 2022;23(11):5966. 10.3390/ijms23115966</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23115966</ArticleId><ArticleId IdType="pmc">PMC9180620</ArticleId><ArticleId IdType="pubmed">35682644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriakopoulos AM, Nigh G, McCullough PA, et al. : Mitogen activated protein kinase (MAPK) activation, p53, and autophagy inhibition characterize the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein induced neurotoxicity. Cureus. 2022;14(12):e32361. 10.7759/cureus.32361</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.32361</ArticleId><ArticleId IdType="pmc">PMC9733976</ArticleId><ArticleId IdType="pubmed">36514706</ArticleId></ArticleIdList></Reference><Reference><Citation>Francisco S, Arranz A, Merino J, et al. : Early p38 activation regulated by MKP-1 Is determinant for high levels of IL-10 expression through TLR2 activation. Front. Immunol. 2021;12:660065. 10.3389/fimmu.2021.660065</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.660065</ArticleId><ArticleId IdType="pmc">PMC8256158</ArticleId><ArticleId IdType="pubmed">34234775</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullough PA, Wynn C, Procter BC: Clinical rationale for SARS-CoV-2 base spike protein detoxification in post COVID-19 and vaccine injury syndromes. J. Am. Physicians Surg. 2023;28(3):90&#x2013;94. 10.5281/zenodo.8286460</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.8286460</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriakopoulos AM, Nigh G, McCullough PA, et al. : Proteolytic targets for SARS-CoV-2 spike protein degradation: Hope for systemic detoxification. J. Am. Physicians Surg. 2023;28(3):86&#x2013;93.</Citation></Reference><Reference><Citation>Khan S, Shafiei MS, Longoria C, et al. : SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-&#x3ba;B pathway. elife. 2021;10:e68563. 10.7554/eLife.68563</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68563</ArticleId><ArticleId IdType="pmc">PMC8709575</ArticleId><ArticleId IdType="pubmed">34866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Iordanov M, Bender K, Ade T, et al. : CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J. 1997;16(5):1009&#x2013;1022. 10.1093/emboj/16.5.1009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/16.5.1009</ArticleId><ArticleId IdType="pmc">PMC1169701</ArticleId><ArticleId IdType="pubmed">9118940</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng M, McFadden G, Greenberg ME: Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron. 1990;4(4):571&#x2013;582. 10.1016/0896-6273(90)90115-v</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(90)90115-v</ArticleId><ArticleId IdType="pubmed">2157471</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhosale PB, Kim HH, Abusaliya A, et al. : Structural and Functional properties of activator protein-1 in cancer and inflammation. Evid. Based Complement. Alternat. Med. 2022;2022:9797929. 10.1155/2022/9797929</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9797929</ArticleId><ArticleId IdType="pmc">PMC9162854</ArticleId><ArticleId IdType="pubmed">35664945</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrns CN, Saikumar J, Bonini NM: Glial AP1 is activated with aging and accelerated by traumatic brain injury. Nat. Aging. 2021;1(7):585&#x2013;597. 10.1038/s43587-021-00072-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-021-00072-0</ArticleId><ArticleId IdType="pmc">PMC8553014</ArticleId><ArticleId IdType="pubmed">34723199</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Nicoll M, Ingham RJ: AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical Hodgkin lymphoma and ALK+&#x2009;ALCL. Exp. Hematol. Oncol. 2021;10(1):4. 10.1186/s40164-020-00197-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40164-020-00197-9</ArticleId><ArticleId IdType="pmc">PMC7792353</ArticleId><ArticleId IdType="pubmed">33413671</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J, Kim JH, Park JG, et al. : Radical scavenging activity-based and AP-1-targeted anti-inflammatory effects of lutein in macrophage-like and skin keratinocytic cells. Mediat. Inflamm. 2013;2013:787042. 10.1155/2013/787042</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/787042</ArticleId><ArticleId IdType="pmc">PMC3606807</ArticleId><ArticleId IdType="pubmed">23533312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriakopoulos AM, Nagl M, Baliou S, et al. : Alleviating promotion of inflammation and cancer induced by nonsteroidal anti-inflammatory drugs. Int. J. Inf. Secur. 2017;2017:9632018. 10.1155/2017/9632018</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/9632018</ArticleId><ArticleId IdType="pmc">PMC5442344</ArticleId><ArticleId IdType="pubmed">28573063</ArticleId></ArticleIdList></Reference><Reference><Citation>Yabluchanskiy A, Ma Y, Iyer RP, et al. : Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology (Bethesda). 2013;28(6):391&#x2013;403. 10.1152/physiol.00029.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00029.2013</ArticleId><ArticleId IdType="pmc">PMC3858212</ArticleId><ArticleId IdType="pubmed">24186934</ArticleId></ArticleIdList></Reference><Reference><Citation>Allport VC, Slater DM, Newton R, et al. : NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol. Hum. Reprod. 2000;6(6):561&#x2013;565. 10.1093/molehr/6.6.561</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molehr/6.6.561</ArticleId><ArticleId IdType="pubmed">10825375</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasier AR: The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc. Res. 2010;86(2):211&#x2013;218. 10.1093/cvr/cvq076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvq076</ArticleId><ArticleId IdType="pmc">PMC2912657</ArticleId><ArticleId IdType="pubmed">20202975</ArticleId></ArticleIdList></Reference><Reference><Citation>Eferl R, Wagner E: AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer. 2003;3:859&#x2013;868. 10.1038/nrc1209</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc1209</ArticleId><ArticleId IdType="pubmed">14668816</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S: Long COVID: An overview. Diabetes Metab. Syndr. 2021;15(3):869&#x2013;875. Erratum in: Diabetes Metab Syndr. 2022; 16(5): 102504. Erratum in: Diabetes Metab Syndr. 2022; 16(12): 102660. 10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z: Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415. 10.1038/s41591-022-02001-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, et al. : Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43(11):1157&#x2013;1172. 10.1093/eurheartj/ehac031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanni SE, Tonon CR, Gatto M, et al. : Post-COVID-19 syndrome: Cardiovascular manifestations. Int. J. Cardiol. 2022;369:80&#x2013;81. 10.1016/j.ijcard.2022.08.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.08.054</ArticleId><ArticleId IdType="pmc">PMC9434909</ArticleId><ArticleId IdType="pubmed">36058345</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;rz M: A case report: Multifocal necrotizing encephalitis and myocarditis after BNT162b2 mRNA vaccination against COVID-19. Vaccines (Basel). 2022;10(10):1651. 10.3390/vaccines10101651</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101651</ArticleId><ArticleId IdType="pmc">PMC9611676</ArticleId><ArticleId IdType="pubmed">36298516</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab C, Domke LM, Hartmann L, et al. : Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination. Clin. Res. Cardiol. 2023;112(3):431&#x2013;440. 10.1007/s00392-022-02129-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-022-02129-5</ArticleId><ArticleId IdType="pmc">PMC9702955</ArticleId><ArticleId IdType="pubmed">36436002</ArticleId></ArticleIdList></Reference><Reference><Citation>Efe C, Kulkarni AV, Terziroli Beretta-Piccoli B, et al. : Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology. 2022;76(6):1576&#x2013;1586. 10.1002/hep.32572</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.32572</ArticleId><ArticleId IdType="pmc">PMC9348326</ArticleId><ArticleId IdType="pubmed">35567545</ArticleId></ArticleIdList></Reference><Reference><Citation>Talotta R: Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to &#x201c;potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases&#x201d;. Clin. Immunol. 2021;224:108665. 10.1016/j.clim.2021.108665</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2021.108665</ArticleId><ArticleId IdType="pmc">PMC7833091</ArticleId><ArticleId IdType="pubmed">33429060</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqatari S, Ismail M, Hasan M, et al. : Emergence of post COVID-19 vaccine autoimmune diseases: A single center study. Infect. Drug Resist. 2023;16:1263&#x2013;1278. 10.2147/IDR.S394602</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S394602</ArticleId><ArticleId IdType="pmc">PMC9994665</ArticleId><ArticleId IdType="pubmed">36910517</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannotta G, Murrone A, Giannotta N: COVID-19 mRNA vaccines: The molecular basis of some adverse events. Vaccines (Basel). 2023;11(4):747. 10.3390/vaccines11040747</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11040747</ArticleId><ArticleId IdType="pmc">PMC10145134</ArticleId><ArticleId IdType="pubmed">37112659</ArticleId></ArticleIdList></Reference><Reference><Citation>Stufano A, Isgr&#xf2; C, Palese LL, et al. : Oxidative damage and post-COVID syndrome: A cross-sectional study in a cohort of Italian workers. Int. J. Mol. Sci. 2023;24(8):7445. 10.3390/ijms24087445</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24087445</ArticleId><ArticleId IdType="pmc">PMC10139201</ArticleId><ArticleId IdType="pubmed">37108606</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilgenberg LGW, Pham B, Ortega M, et al. : Agrin regulation of alpha3 sodium-potassium ATPase activity modulates cardiac myocyte contraction. J. Biol. Chem. 2009;284(25):16956&#x2013;16965. 10.1074/jbc.M806855200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M806855200</ArticleId><ArticleId IdType="pmc">PMC2719333</ArticleId><ArticleId IdType="pubmed">19376779</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group: Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir. Med. 2022;10(8):761&#x2013;775. 10.1016/S2213-2600(22)00127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, et al. : Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2021;118(34):e2024358118. 10.1073/pnas.2024358118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Rocca CCA, Serafim AP, et al. : Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers. Front. Immunol. 2023;14:1174020. 10.3389/fimmu.2023.1174020</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1174020</ArticleId><ArticleId IdType="pmc">PMC10242059</ArticleId><ArticleId IdType="pubmed">37287969</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#x131;l&#x131;&#xe7; Y, &#xd6;zer A, Tatar T, et al. : Effect of picroside II on hind limb ischemia reperfusion injury in rats. Drug Des. Devel. Ther. 2017;11:1917&#x2013;1925. 10.2147/DDDT.S132401</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S132401</ArticleId><ArticleId IdType="pmc">PMC5500556</ArticleId><ArticleId IdType="pubmed">28721011</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;&#xe7;&#xfc;k A, Polat Y, K&#x131;l&#x131;&#xe7;arslan A, et al. : Irisin protects against hind limb ischemia reperfusion injury. Drug Des. Devel. Ther. 2021;15:361&#x2013;368. 10.2147/DDDT.S279318</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S279318</ArticleId><ArticleId IdType="pmc">PMC7871175</ArticleId><ArticleId IdType="pubmed">33574655</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntouros PA, Kravvariti E, Vlachogiannis NI, et al. : Oxidative stress and endogenous DNA damage in blood mononuclear cells may predict anti-SARS-CoV-2 antibody titers after vaccination in older adults. Biochim. Biophys. Acta Mol. basis Dis. 2022;1868(6):166393. 10.1016/j.bbadis.2022.166393</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2022.166393</ArticleId><ArticleId IdType="pmc">PMC8930778</ArticleId><ArticleId IdType="pubmed">35314351</ArticleId></ArticleIdList></Reference><Reference><Citation>Espino J, Pariente JA, Rodr&#xed;guez AB: Oxidative stress and immunosenescence: therapeutic effects of melatonin. Oxidative Med. Cell. Longev. 2012;2012:670294. 10.1155/2012/670294</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/670294</ArticleId><ArticleId IdType="pmc">PMC3549369</ArticleId><ArticleId IdType="pubmed">23346283</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunsch C, Medford RM: Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res. 1999;85(8):753&#x2013;766. 10.1161/01.res.85.8.753</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.res.85.8.753</ArticleId><ArticleId IdType="pubmed">10521248</ArticleId></ArticleIdList></Reference><Reference><Citation>Won T, Gilotra NA, Wood MK, et al. : Increased interleukin 18-dependent immune responses are associated with myopericarditis after COVID-19 mRNA vaccination. Front. Immunol. 2022;13:851620. 10.3389/fimmu.2022.851620</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.851620</ArticleId><ArticleId IdType="pmc">PMC8894592</ArticleId><ArticleId IdType="pubmed">35251049</ArticleId></ArticleIdList></Reference><Reference><Citation>Dashwood A, Cheesman E, Beard N, et al. : Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure. ACS Pharmacol. Transl. Sci. 2020;3(4):563&#x2013;582. 10.1021/acsptsci.0c00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsptsci.0c00003</ArticleId><ArticleId IdType="pmc">PMC7432681</ArticleId><ArticleId IdType="pubmed">32832863</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JK, Kim SH, Lewis EC, et al. : Differences in signaling pathways by IL-1beta and IL-18. Proc. Natl. Acad. Sci. USA. 2004;101(23):8815&#x2013;8820. 10.1073/pnas.0402800101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402800101</ArticleId><ArticleId IdType="pmc">PMC423278</ArticleId><ArticleId IdType="pubmed">15161979</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu SN, Chen YS, Hsu CC, et al. : Changes of ECG parameters after BNT162b2 vaccine in the senior high school students. Eur. J. Pediatr. 2023;182(3):1155&#x2013;1162. 10.1007/s00431-022-04786-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04786-0</ArticleId><ArticleId IdType="pmc">PMC9813456</ArticleId><ArticleId IdType="pubmed">36602621</ArticleId></ArticleIdList></Reference><Reference><Citation>Genco L, Cantelli M, Noto M, et al. : Alopecia Areata after COVID-19 vaccines. Skin Appendage Disord. 2023;9(2):141&#x2013;143. 10.1159/000528719</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000528719</ArticleId><ArticleId IdType="pmc">PMC9892995</ArticleId><ArticleId IdType="pubmed">36926281</ArticleId></ArticleIdList></Reference><Reference><Citation>Prie BE, Voiculescu VM, Ionescu-Bozdog OB, et al. : Oxidative stress and alopecia areata. J. Med. Life. 2015;8 Spec Issue:43&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4564047</ArticleId><ArticleId IdType="pubmed">26361510</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamukcu B, Lip GY, Shantsila E: The nuclear factor--kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. Thromb. Res. 2011;128(2):117&#x2013;123. 10.1016/j.thromres.2011.03.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2011.03.025</ArticleId><ArticleId IdType="pubmed">21636112</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer CA, Le Haen PA, Dijk RA, et al. : Activator protein-1 (AP-1) signalling in human atherosclerosis: results of a systematic evaluation and intervention study. Clin. Sci. (Lond.). 2012;122(9):421&#x2013;428. 10.1042/CS20110234</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20110234</ArticleId><ArticleId IdType="pmc">PMC3259695</ArticleId><ArticleId IdType="pubmed">22092038</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Maes M: Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). Curr. Neuropharmacol. 2014;12(2):168&#x2013;185. 10.2174/1570159X11666131120224653</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X11666131120224653</ArticleId><ArticleId IdType="pmc">PMC3964747</ArticleId><ArticleId IdType="pubmed">24669210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray PD, Huang BW, Tsuji Y: Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 2012;24(5):981&#x2013;990. 10.1016/j.cellsig.2012.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2012.01.008</ArticleId><ArticleId IdType="pmc">PMC3454471</ArticleId><ArticleId IdType="pubmed">22286106</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaienko R, Bovo E, Zima AV: Redox dependent modifications of ryanodine receptor: Basic mechanisms and implications in heart diseases. Front. Physiol. 2018;9:1775. 10.3389/fphys.2018.01775</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.01775</ArticleId><ArticleId IdType="pmc">PMC6291498</ArticleId><ArticleId IdType="pubmed">30574097</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss A, Juh&#xe1;sz L, Sepr&#xe9;nyi G, et al. : The role of nitric oxide, superoxide and peroxynitrite in the anti-arrhythmic effects of preconditioning and peroxynitrite infusion in anaesthetized dogs. Br. J. Pharmacol. 2010;160(5):1263&#x2013;1272. 10.1111/j.1476-5381.2010.00774.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2010.00774.x</ArticleId><ArticleId IdType="pmc">PMC2936034</ArticleId><ArticleId IdType="pubmed">20590618</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephan BCM, Harrison SL, Keage HAD, et al. : Cardiovascular disease, the nitric oxide pathway and risk of cognitive impairment and dementia. Curr. Cardiol. Rep. 2017;19(9):87. 10.1007/s11886-017-0898-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-017-0898-y</ArticleId><ArticleId IdType="pmc">PMC5554286</ArticleId><ArticleId IdType="pubmed">28801790</ArticleId></ArticleIdList></Reference><Reference><Citation>Raddino R, Caretta G, Teli M, et al. : Nitric oxide and cardiovascular risk factors. Heart Int. 2007;3(1):18. 10.4081/hi.2007.18</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/hi.2007.18</ArticleId><ArticleId IdType="pmc">PMC3184682</ArticleId><ArticleId IdType="pubmed">21977271</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma JN, Al-Omran A, Parvathy SS: Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 2007;15(6):252&#x2013;259. 10.1007/s10787-007-0013-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-007-0013-x</ArticleId><ArticleId IdType="pubmed">18236016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueki Y, Miyake S, Tominaga Y, et al. : Increased nitric oxide levels in patients with rheumatoid arthritis. J. Rheumatol. 1996;23(2):230&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">8882024</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright AL, Zinn R, Hohensinn B, et al. : Neuroinflammation and neuronal loss precede A&#x3b2; plaque deposition in the hAPP-J20 mouse model of Alzheimer&#x2019;s disease. PLoS One. 2013;8(4):e59586. 10.1371/journal.pone.0059586</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0059586</ArticleId><ArticleId IdType="pmc">PMC3613362</ArticleId><ArticleId IdType="pubmed">23560052</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims NR, Anderson MF: Mitochondrial contributions to tissue damage in stroke. Neurochem. Int. 2002;40(6):511&#x2013;526. 10.1016/s0197-0186(01)00122-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0197-0186(01)00122-x</ArticleId><ArticleId IdType="pubmed">11850108</ArticleId></ArticleIdList></Reference><Reference><Citation>Protonotarios A, Elliott PM: Arrhythmogenic cardiomyopathy: A disease or merely a phenotype? Eur. Cardiol. 2020;15:1&#x2013;5. 10.15420/ecr.2019.05</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2019.05</ArticleId><ArticleId IdType="pmc">PMC7066858</ArticleId><ArticleId IdType="pubmed">32180838</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, Swank Z, Bartsch YC, et al. : Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis. Circulation. 2023;147(11):867&#x2013;876. 10.1161/CIRCULATIONAHA</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA</ArticleId><ArticleId IdType="pmc">PMC10010667</ArticleId><ArticleId IdType="pubmed">36597886</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumanova NG, Deev AD, Kots AY, et al. : Elevated levels of serum nitrite and nitrate, NOx, are associated with increased total and cardiovascular mortality in an 8-year follow-up study. Eur. J. Clin. Investig. 2019;49(3):e13061. 10.1111/eci.13061</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13061</ArticleId><ArticleId IdType="pubmed">30554409</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Yuan Q, Chen F, et al. : Fundamental mechanisms of the cell death caused by nitrosative stress. Front. Cell Dev. Biol. 2021;9:742483. 10.3389/fcell.2021.742483</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.742483</ArticleId><ArticleId IdType="pmc">PMC8488117</ArticleId><ArticleId IdType="pubmed">34616744</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough E, Inigo J, Chandra D, et al. : Mitochondrial dynamics in SARS-CoV2 spike protein treated human microglia: Implications for neuro-COVID. J. Neuroimmune Pharmacol. 2021;16(4):770&#x2013;784. 10.1007/s11481-021-10015-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10015-6</ArticleId><ArticleId IdType="pmc">PMC8487226</ArticleId><ArticleId IdType="pubmed">34599743</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone S, Longini M, Marzocchi B, et al. : Effects of lutein on oxidative stress in the term newborn: a pilot study. Neonatology. 2010;97(1):36&#x2013;40. 10.1159/000227291</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000227291</ArticleId><ArticleId IdType="pubmed">19590244</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone S, Tei M, Longini M, et al. : Lipid and protein oxidation in newborn infants after lutein administration. Oxidative Med. Cell. Longev. 2014;2014:781454. 10.1155/2014/781454</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/781454</ArticleId><ArticleId IdType="pmc">PMC4021681</ArticleId><ArticleId IdType="pubmed">24876916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuligowski J, Vento M: Metabolomics, oxidative, and nitrosative stress in the perinatal period. Antioxidants (Basel). 2022;11(7):1357. 10.3390/antiox11071357</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11071357</ArticleId><ArticleId IdType="pmc">PMC9311970</ArticleId><ArticleId IdType="pubmed">35883848</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SY, Fu ZJ, Ma H, et al. : Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion. Invest. Ophthalmol. Vis. Sci. 2009;50(2):836&#x2013;843. 10.1167/iovs.08-2310</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.08-2310</ArticleId><ArticleId IdType="pubmed">18936152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruban AV, Pascal A, Lee PJ, et al. : Molecular configuration of xanthophyll cycle carotenoids in photosystem II antenna complexes. J. Biol. Chem. 2002;277(45):42937&#x2013;42942. 10.1074/jbc.M207823200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207823200</ArticleId><ArticleId IdType="pubmed">12207030</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafi MM, Shafaie Y: Dietary lutein modulates inducible nitric oxide synthase (iNOS) gene and protein expression in mouse macrophage cells (RAW 264.7). Mol. Nutr. Food Res. 2007;51(3):333&#x2013;340. 10.1002/mnfr.200600170</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.200600170</ArticleId><ArticleId IdType="pubmed">17340577</ArticleId></ArticleIdList></Reference><Reference><Citation>Pap R, Pandur E, J&#xe1;nosa G, et al. : Lutein decreases inflammation and oxidative stress and prevents iron accumulation and lipid peroxidation at glutamate-induced neurotoxicity. Antioxidants (Basel). 2022;11(11):2269. 10.3390/antiox11112269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11112269</ArticleId><ArticleId IdType="pmc">PMC9687421</ArticleId><ArticleId IdType="pubmed">36421455</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano T: Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2010;86(7):717&#x2013;730. 10.2183/pjab.86.717</Citation><ArticleIdList><ArticleId IdType="doi">10.2183/pjab.86.717</ArticleId><ArticleId IdType="pmc">PMC3066534</ArticleId><ArticleId IdType="pubmed">20689230</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindhu ER, Preethi KC, Kuttan R: Antioxidant activity of carotenoid lutein in vitro and in vivo. Indian J. Exp. Biol. 2010;48(8):843&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">21341544</ArticleId></ArticleIdList></Reference><Reference><Citation>Krinsky NI, Landrum JT, Bone RA: Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu. Rev. Nutr. 2003;23:171&#x2013;201. 10.1146/annurev.nutr.23.011702.073307</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.nutr.23.011702.073307</ArticleId><ArticleId IdType="pubmed">12626691</ArticleId></ArticleIdList></Reference><Reference><Citation>Vishwanathan R, Neuringer M, Snodderly DM, et al. : Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates. Nutr. Neurosci. 2013;16(1):21&#x2013;29. 10.1179/1476830512Y.0000000024</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1476830512Y.0000000024</ArticleId><ArticleId IdType="pmc">PMC3824968</ArticleId><ArticleId IdType="pubmed">22780947</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwyer JH, Navab M, Dwyer KM, et al. : Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study. Circulation. 2001;103(24):2922&#x2013;2927. 10.1161/01.cir.103.24.2922</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.103.24.2922</ArticleId><ArticleId IdType="pubmed">11413081</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Qi Z, Liu W, et al. : Lutein protects against ischemia/reperfusion injury in rat kidneys. Mol. Med. Rep. 2015;11(11):2179&#x2013;2184. 10.3892/mmr.2014.2982</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2014.2982</ArticleId><ArticleId IdType="pubmed">25412035</ArticleId></ArticleIdList></Reference><Reference><Citation>Koushan K, Rusovici R, Li W, et al. : The role of lutein in eye-related disease. Nutrients. 2013;5(5):1823&#x2013;1839. 10.3390/nu5051823</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu5051823</ArticleId><ArticleId IdType="pmc">PMC3708350</ArticleId><ArticleId IdType="pubmed">23698168</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z, Kong G, Wang F, et al. : Improvement in the stability and bioavailability of pumpkin lutein using &#x3b2;-cyclodextrin microcapsules. Food Sci. Nutr. 2023;11(6):3067&#x2013;3074. 10.1002/fsn3.3288</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/fsn3.3288</ArticleId><ArticleId IdType="pmc">PMC10261736</ArticleId><ArticleId IdType="pubmed">37324919</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozaffarieh M, Sacu S, Wedrich A: The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence. Nutr. J. 2003;2:20. 10.1186/1475-2891-2-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2891-2-20</ArticleId><ArticleId IdType="pmc">PMC305368</ArticleId><ArticleId IdType="pubmed">14670087</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Roger Illingworth D, Connor SL, et al. : Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene. Eur. J. Nutr. 2010;49(6):327&#x2013;336. 10.1007/s00394-009-0089-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-009-0089-8</ArticleId><ArticleId IdType="pubmed">20082082</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohn T, Desmarchelier C, El SN, et al. : &#x3b2;-Carotene in the human body: metabolic bioactivation pathways - from digestion to tissue distribution and excretion. Proc. Nutr. Soc. 2019;78(1):68&#x2013;87. 10.1017/S0029665118002641</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0029665118002641</ArticleId><ArticleId IdType="pubmed">30747092</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson EJ, Maras JE, Rasmussen HM, et al. : Intake of lutein and zeaxanthin differ with age, sex, and ethnicity. J. Am. Diet. Assoc. 2010;110(9):1357&#x2013;1362. 10.1016/j.jada.2010.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jada.2010.06.009</ArticleId><ArticleId IdType="pubmed">20800129</ArticleId></ArticleIdList></Reference><Reference><Citation>Montesano D, Rocchetti G, Cossignani L, et al. : Untargeted metabolomics to evaluate the stability of extra-virgin olive oil with added Lycium barbarum carotenoids during storage. Foods. 2019;8(6):179. 10.3390/foods8060179</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods8060179</ArticleId><ArticleId IdType="pmc">PMC6616970</ArticleId><ArticleId IdType="pubmed">31141920</ArticleId></ArticleIdList></Reference><Reference><Citation>
European Union:
On the characteristics of olive oil and olive-residue oil and on the relevant methods of analysis. Commission Regulation (EEC) No 2568/91.
July 11, 1991.
Reference Source
</Citation></Reference><Reference><Citation>Mousavi S, Mariotti R, Stanzione V, et al. : Evolution of extra virgin olive oil quality under different storage conditions. Foods. 2021;10(8):1945. 10.3390/foods10081945</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods10081945</ArticleId><ArticleId IdType="pmc">PMC8391879</ArticleId><ArticleId IdType="pubmed">34441722</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankel EN: Chemistry of extra virgin olive oil: adulteration, oxidative stability, and antioxidants. J. Agric. Food Chem. 2010;58(10):5991&#x2013;6006. 10.1021/jf1007677</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf1007677</ArticleId><ArticleId IdType="pubmed">20433198</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kyriakopoulos AM:
N-bromotaurine solutions and emulsions against abnormal cells. Patent #10,772,855.
September 15, 2020.
Reference Source
</Citation></Reference><Reference><Citation>Kyriakopoulos AM, Nagl M, Gupta RC, et al. : Taurine and N-bromotaurine in topical treatment of psoriasis. Adv. Exp. Med. Biol. 2022;1370:99&#x2013;111. 10.1007/978-3-030-93337-1_9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-93337-1_9</ArticleId><ArticleId IdType="pubmed">35882785</ArticleId></ArticleIdList></Reference><Reference><Citation>Geromichalou EG, Geromichalos GD: In silico approach for the evaluation of the potential antiviral activity of extra virgin olive oil (EVOO) bioactive constituents oleuropein and oleocanthal on spike therapeutic drug target of SARS-CoV-2. Molecules. 2022;27(21):7572. 10.3390/molecules27217572</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27217572</ArticleId><ArticleId IdType="pmc">PMC9655607</ArticleId><ArticleId IdType="pubmed">36364398</ArticleId></ArticleIdList></Reference><Reference><Citation>Borkotoky S, Dey D, Hazarika Z: Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective. Mol. Biol. Rep. 2023;50(3):2713&#x2013;2721. 10.1007/s11033-022-08193-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-08193-4</ArticleId><ArticleId IdType="pmc">PMC9786537</ArticleId><ArticleId IdType="pubmed">36562937</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, et al. : Persistence of SARS-CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front. Immunol. 2022;12:746021. 10.3389/fimmu.2021.746021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Imran M, Thabet HK, Alaqel SI, et al. : The therapeutic and prophylactic potential of quercetin against COVID-19: An outlook on the clinical studies, inventive compositions, and patent literature. Antioxidants (Basel). 2022;11(5):876. 10.3390/antiox11050876</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11050876</ArticleId><ArticleId IdType="pmc">PMC9137692</ArticleId><ArticleId IdType="pubmed">35624740</ArticleId></ArticleIdList></Reference><Reference><Citation>Nag A, Banerjee R, Paul S, et al. : Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study. Comput. Biol. Med. 2022;146:105552. 10.1016/j.compbiomed.2022.105552</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2022.105552</ArticleId><ArticleId IdType="pmc">PMC9044632</ArticleId><ArticleId IdType="pubmed">35508082</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh MV, Francis S, Aktay S, et al. : Therapeutic potential of curcumin in ARDS and COVID-19. Clin. Exp. Pharmacol. Physiol. 2023;50(4):267&#x2013;276. 10.1111/1440-1681.13744</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1440-1681.13744</ArticleId><ArticleId IdType="pmc">PMC9877870</ArticleId><ArticleId IdType="pubmed">36480131</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty AJ, Mitra S, Tallei TE, et al. : Bromelain a potential bioactive compound: A comprehensive overview from a pharmacological perspective. Life (Basel). 2021;11(4):317. 10.3390/life11040317</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life11040317</ArticleId><ArticleId IdType="pmc">PMC8067380</ArticleId><ArticleId IdType="pubmed">33917319</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanikawa T, Kiba Y, Yu J, et al. : Degradative effect of nattokinase on spike protein of SARS-CoV-2. Molecules. 2022;27(17):5405. 10.3390/molecules27175405</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27175405</ArticleId><ArticleId IdType="pmc">PMC9458005</ArticleId><ArticleId IdType="pubmed">36080170</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>